Efficacy of hydroxyurea in providing transfusion independence in β-thalassemia. (ανοίγει νέο παράθυρο)

Ansari SH, Shamsi TS, Ashraf M, Perveen K, Farzana T, Bohray M, Erum S, Mehboob T.

Πηγή‎: J Pediatr Hematol Oncol 2011;33(5):339-43.

Καταχώριση‎: PubMed 21602718

DOI‎: 10.1097/MPH.0b013e31821b0770

https://www.ncbi.nlm.nih.gov/pubmed/21602718 (ανοίγει νέο παράθυρο)

Hydroxyurea treatment in β-thalassemia patients: to respond or not to respond? (ανοίγει νέο παράθυρο)

Banan M.

Πηγή‎: Ann Hematol 2013;92(3):289-99.

Καταχώριση‎: PubMed 23318979

DOI‎: 10.1007/s00277-012-1671-3

https://www.ncbi.nlm.nih.gov/pubmed/23318979 (ανοίγει νέο παράθυρο)

Decreased transfusion needs associated with hydroxyurea therapy in Algerian patients with thalassemia major or intermedia. (ανοίγει νέο παράθυρο)

Bradai M, Pissard S, Abad MT, Dechartres A, Ribeil JA, Landais P, de Montalembert M.

Πηγή‎: Transfusion 2007;47(10):1830-6.

Καταχώριση‎: PubMed 17880608

DOI‎: 10.1111/j.1537-2995.2007.01399.x

https://www.ncbi.nlm.nih.gov/pubmed/17880608 (ανοίγει νέο παράθυρο)

Hydroxyurea increases hemoglobin F levels and improves the effectiveness of erythropoiesis in beta-thalassemia/hemoglobin E disease. (ανοίγει νέο παράθυρο)

Fucharoen S, Siritanaratkul N, Winichagoon P, Chowthaworn J, Siriboon W, Muangsup W, Chaicharoen S, Poolsup N, Chindavijak B, Pootrakul P, Piankijagum A, Schechter AN, Rodgers GP.

Πηγή‎: Blood 1996;87(3):887-92.

Καταχώριση‎: PubMed 8562958

https://www.ncbi.nlm.nih.gov/pubmed/8562958 (ανοίγει νέο παράθυρο)

Hydroxyurea can reduce or eliminate transfusion requirements in children with major and intermediate thalassemia. (ανοίγει νέο παράθυρο)

Hashemi A, Abrishamkar M, Jenabzade AR, Eslami Z.

Πηγή‎: Iran J Blood Cancer 2009;1(4):147-50.

Καταχώριση‎: IMEMR 107228

https://www.ijbc.ir/browse.php?a_id=4&sid=1&slc_lang=en (ανοίγει νέο παράθυρο)

Hydroxyurea as a first-line treatment of extramedullary hematopoiesis in patients with beta thalassemia: Four case reports. (ανοίγει νέο παράθυρο)

Karimi M, Cohan N, Pishdad P.

Πηγή‎: Hematology 2015;20(1):53-7.

Καταχώριση‎: PubMed 24717020

DOI‎: 10.1179/1607845414Y.0000000168

https://www.ncbi.nlm.nih.gov/pubmed/24717020 (ανοίγει νέο παράθυρο)

Genotype-phenotype relationship of patients with β-thalassemia taking hydroxyurea: a 13-year experience in Iran. (ανοίγει νέο παράθυρο)

Karimi M, Haghpanah S, Farhadi A, Yavarian M.

Πηγή‎: Int J Hematol 2012;95(1):51-6.

Καταχώριση‎: PubMed 22180324

DOI‎: 10.1007/s12185-011-0985-6

https://www.ncbi.nlm.nih.gov/pubmed/22180324 (ανοίγει νέο παράθυρο)

Report on Patients with Non Transfusion-Dependent β-Thalassemia Major Being Treated with Hydroxyurea Attending the Thalassemia Research Center, Sari, Mazandaran Province, Islamic Republic of Iran in 2013. (ανοίγει νέο παράθυρο)

Kosaryan M, Karami H, Zafari M, Yaghobi N.

Πηγή‎: Hemoglobin 2014;38(2):115-8.

Καταχώριση‎: PubMed 24471558

DOI‎: 10.3109/03630269.2013.869229

https://www.ncbi.nlm.nih.gov/pubmed/24471558 (ανοίγει νέο παράθυρο)

Clinical experience with fetal hemoglobin induction therapy in patients with β-thalassemia. (ανοίγει νέο παράθυρο)

Musallam KM, Taher AT, Cappellini MD, Sankaran VG.

Πηγή‎: Blood 2013;121(12):2199-212.

Καταχώριση‎: PubMed 23315167

DOI‎: 10.1182/blood-2012-10-408021

https://www.ncbi.nlm.nih.gov/pubmed/23315167 (ανοίγει νέο παράθυρο)

A randomised double-blind placebo-controlled clinical trial of oral hydroxyurea for transfusion-dependent β-thalassaemia. (ανοίγει νέο παράθυρο)

Yasara N, Wickramarathne N, Mettananda C, Silva I, Hameed N, Attanayaka K, Rodrigo R, Wickramasinghe N, Perera L, Manamperi A, Premawardhena A, Mettananda S

Πηγή‎: Sci Rep. 2022;12(1):2752.

Καταχώριση‎: PubMed 35177777

DOI‎: 10.1038/s41598-022-06774-8

https://pubmed.ncbi.nlm.nih.gov/35177777/ (ανοίγει νέο παράθυρο)

Response to hydroxyurea treatment in Iranian transfusion-dependent beta-thalassemia patients. (ανοίγει νέο παράθυρο)

Yavarian M, Karimi M, Bakker E, Harteveld CL, Giordano PC.

Πηγή‎: Haematologica 2004;89(10):1172-8.

Καταχώριση‎: PubMed 15477200

https://www.ncbi.nlm.nih.gov/pubmed/15477200 (ανοίγει νέο παράθυρο)

Hydroxyurea therapy in 49 patients with major beta-thalassemia. (ανοίγει νέο παράθυρο)

Zamani F, Shakeri R, Eslami SM, Razavi SM, Basi A.

Πηγή‎: Arch Iran Med 2009;12(3):295-7.

Καταχώριση‎: PubMed 19400608

https://www.ncbi.nlm.nih.gov/pubmed/19400608 (ανοίγει νέο παράθυρο)

Preliminary results with administration of recombinant human erythropoietin in sickle cell/beta-thalassemia patients during pregnancy. (ανοίγει νέο παράθυρο)

Bourantas K, Makrydimas G, Georgiou J, Tsiara S, Lolis D.

Πηγή‎: Eur J Haematol 1996;56(5):326-8.

Καταχώριση‎: PubMed 8641410

https://www.ncbi.nlm.nih.gov/pubmed/8641410 (ανοίγει νέο παράθυρο)

Induction of fetal hemoglobin synthesis with recombinant human erythropoietin in anemic patients with heterozygous beta-thalassemia during pregnancy. (ανοίγει νέο παράθυρο)

Breymann C, Fibach E, Visca E, Huettner C, Huch A, Huch R.

Πηγή‎: J Matern Fetal Med 1999;8(1):1-7.

Καταχώριση‎: PubMed 10052837

DOI‎: 10.1002/(SICI)1520-6661(199901/02)8:1<1::AID-MFM1>3.0.CO;2-O

https://www.ncbi.nlm.nih.gov/pubmed/10052837 (ανοίγει νέο παράθυρο)

Treatment of beta-thalassemia patients with recombinant human erythropoietin: effect on transfusion requirements and soluble adhesion molecules. (ανοίγει νέο παράθυρο)

Chaidos A, Makis A, Hatzimichael E, Tsiara S, Gouva M, Tzouvara E, Bourantas KL.

Πηγή‎: Acta Haematol 2004;111(4):189-95.

Καταχώριση‎: PubMed 15153710

DOI‎: 10.1159/000077551

https://www.ncbi.nlm.nih.gov/pubmed/15153710 (ανοίγει νέο παράθυρο)

Recombinant human erythropoietin therapy in a transfusion-dependent β-thalassemia major patient. (ανοίγει νέο παράθυρο)

Makis AC, Chaliasos N, Hatzimichael EC, Bourantas KL.

Πηγή‎: Ann Hematol 2001;80(8):492-5.

Καταχώριση‎: PubMed 11563599

https://www.ncbi.nlm.nih.gov/pubmed/11563599 (ανοίγει νέο παράθυρο)

Fetal globin induction--can it cure beta thalassemia? (ανοίγει νέο παράθυρο)

Perrine SP.

Πηγή‎: Hematology Am Soc Hematol Educ Program 2005:38-44.

Καταχώριση‎: PubMed 16304357

DOI‎: 10.1182/asheducation-2005.1.38

https://www.ncbi.nlm.nih.gov/pubmed/16304357 (ανοίγει νέο παράθυρο)